Status:
COMPLETED
A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria
Lead Sponsor:
Pfizer
Conditions:
Pneumococcal Infections
Eligibility:
All Genders
121-72 years
Phase:
PHASE4
Brief Summary
A vaccine called Prevenar is already approved for use in China for vaccination of children younger than 6 years old against infections caused by Streptococcus pneumoniae. This study is to measure the...
Eligibility Criteria
Inclusion
- Healthy Chinese male or female subjects.
- Between 121 days to less than 72 months of age at the time of entry into the study.
Exclusion
- Receipt of previous vaccine against Pneumo
- Previous anaphylactic reaction to any vaccine or part of a vaccine
- Previous proven invasive Pneumo infection
- Receipt of investigational drug or device within the proceeding 28 days
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
505 Patients enrolled
Trial Details
Trial ID
NCT01193582
Start Date
September 1 2010
End Date
September 1 2012
Last Update
November 20 2013
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Baolixiang Clinic
Baoli Town,Yongfu County, Guangxi, China, 541902
2
Guangfuxiang Clinic
Guangfu Town, Yongfu County, Guangxi, China, 541803
3
Luojin Clinic
Luojin Town, Yongfu County, Guangxi, China, 541801
4
Yongfu County CDC
Yongfu County, Guangxi, China, 541800